| 20551-8 |
Nalbuphine |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
Nalbuphine [Mass/volume] in Urine by Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
20551-8 |
|
Confirm |
|
|
Both |
|
|
|
0 |
Nalbuphine Ur Cfm-mCnc |
|
|
|
Y |
|
Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; LC/MS/MS; Level; Mass concentration; Nubain; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.73 |
1.0m |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 20552-6 |
Nitrazepam |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
Nitrazepam [Mass/volume] in Urine by Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
20552-6 |
|
Confirm |
|
|
Both |
|
|
|
0 |
Nitrazepam Ur Cfm-mCnc |
|
|
|
Y |
|
Alodorm; APODORM; AREM; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Dormigen; Dormo-puren; DRUG/TOXICOLOGY; Drugs; Eatan N; GCMS; Imeson; Insoma; Ipersed; LC/MS/MS; Level; Mass concentration; Mitidin; Mogadan; Mogadon; Nitrados; Nitrazepan; Novanox; Ormodon; Paxadorm; Pelson; Point in time; QNT; Quan; Quant; Quantitative; Random; Remnos; Serenade; Somnibel n; Somniper; Somnite; Surem; UA; UR; Urn |
2.73 |
1.0m |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 20553-4 |
Norfluoxetine |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
Norfluoxetine [Mass/volume] in Urine by Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
20553-4 |
|
Confirm |
|
|
Both |
|
|
|
0 |
Norfluoxetine Ur Cfm-mCnc |
|
|
|
Y |
|
(S)-Norfluoxetine; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Desmethylfluoxetine; DRUG/TOXICOLOGY; Drugs; Fluoxetine metabolite; GCMS; LC/MS/MS; Level; Mass concentration; Norfluoxetin; Point in time; QNT; Quan; Quant; Quantitative; Random; Seproxetine; UA; UR; Urn |
2.73 |
1.0m |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 20554-2 |
Para hydroxyamphetamine |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
Para hydroxyamphetamine [Mass/volume] in Urine by Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
20554-2 |
|
Confirm |
|
|
Both |
|
|
|
0 |
P-OH-Amphet Ur Cfm-mCnc |
|
|
|
Y |
|
Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; LC/MS/MS; Level; Mass concentration; Methylthyramine; Para hydroxy amphetamine; P-OH-Amphet; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.42 |
1.0m |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 20555-9 |
Phenmetrazine |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
Phenmetrazine [Mass/volume] in Urine by Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
20555-9 |
|
Confirm |
|
|
Both |
|
|
|
0 |
Phenmetrazine Ur Cfm-mCnc |
|
|
|
Y |
|
Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; LC/MS/MS; Level; Mass concentration; Oxazimedrine; Point in time; PotentialForAbuse; Preludin endurets; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.42 |
1.0m |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
| 20556-7 |
Phenothiazines |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
Phenothiazines [Mass/volume] in Urine by Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
20556-7 |
|
Confirm |
|
|
Both |
|
|
|
0 |
Phenothiaz Ur Cfm-mCnc |
|
|
|
Y |
|
Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Dibenzothiazine; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; Phenothiaz; Phenothiazine; Phenothiazn; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.52 |
1.0m |
|
|
|
|
|
|
|
ug/mL |
|
|
Changed component name from "Phenothiazine" (singular) to "Phenothiazines" (pleural) to better reflect its long term intended meaning and current conventions. . Phenothiazine is a distinct chemical but has never been used in human medicine. (It was used for parasitic diseases in animals decades ago but not now). The word phenothiazine has always been used to mean the class of drugs that are derived from phenothiazine and laboratories that use phenothiazine and phenothiazines to mean the measure of any drug of phenothiazine class contained in the specimen. |
0 |
| 20557-5 |
Phentermine |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
Phentermine [Mass/volume] in Urine by Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
20557-5 |
|
Confirm |
|
|
Both |
|
|
|
0 |
Phentermine Ur Cfm-mCnc |
|
|
|
Y |
|
Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Ionamin; LC/MS/MS; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.73 |
1.0m |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
| 20558-3 |
Psilocin |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
Psilocin [Mass/volume] in Urine by Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
20558-3 |
|
Confirm |
|
|
Both |
|
|
|
0 |
Psilocin Ur Cfm-mCnc |
|
|
|
Y |
|
4-hydroxy-dimethyltryptamine; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.42 |
1.0m |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 20559-1 |
Temazepam |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
Temazepam [Mass/volume] in Urine by Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
20559-1 |
|
Confirm |
|
|
Both |
|
|
|
0 |
Temazepam Ur Cfm-mCnc |
|
|
|
Y |
|
Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; Normison; Point in time; QNT; Quan; Quant; Quantitative; Random; Restoril; UA; UR; Urn |
2.73 |
1.0m |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 2056-0 |
Catecholamines |
MCnc |
Plas |
Pt |
Qn |
|
|
ACTIVE |
Catecholamines [Mass/volume] in Plasma |
|
MIN |
DefinitionDescription |
|
|
pg/mL |
|
|
|
|
|
|
CHEM |
|
2056-0 |
|
|
|
|
Both |
|
|
|
0 |
Catechols Plas-mCnc |
|
|
|
Y |
|
Cate; Catec; Catech; Catechol; Catecholamine; Catecholamines.total; Catechols; Chemistry; Endocrine; Endocrinology; Epinephrine+norepinephrine+dopamine; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.73 |
1 |
|
|
|
|
|
|
|
pg/mL |
|
|
|
0 |
| 20560-9 |
Thioridazine |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
Thioridazine [Mass/volume] in Urine by Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
20560-9 |
|
Confirm |
|
|
Both |
|
|
|
0 |
Thioridazine Ur Cfm-mCnc |
|
|
|
Y |
|
Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; Mellaril; Novo-ridazine; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonapax; Thioridazine Hydrochloride; Thioril; UA; UR; Urn |
2.42 |
1.0m |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
| 20561-7 |
traMADol |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
traMADol [Mass/volume] in Urine by Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
20561-7 |
|
Confirm |
|
|
Both |
|
|
|
0 |
traMADol Ur Cfm-mCnc |
|
|
|
Y |
|
Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; LC/MS/MS; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Tramal; UA; Ultram; UR; Urn |
2.73 |
1.0m |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
| 20562-5 |
Stroke volume |
Vol |
Heart.ventricle.left |
Pt |
Qn |
|
|
ACTIVE |
Left ventricular Stroke volume |
|
MIN |
DefinitionDescription |
|
|
mL |
|
|
|
|
|
|
HEMODYN.MOLEC |
|
20562-5 |
|
|
|
|
|
|
|
|
0 |
LV SV |
|
|
|
Y |
|
Cardiac; Cardiac output/Heart beat; Cardio; Cardiology; Heart Disease; Hemodynamics; HEMODYNAMICS.MOLEC; Hrt; Hrt ventr; L; LT; LV; Point in time; QNT; Quan; Quant; Quantitative; Random; SV; Ventricular; Vol; Volume |
2.73 |
1.0m |
|
|
|
|
|
|
|
mL |
|
|
|
0 |
| 20563-3 |
Carboxyhemoglobin/Hemoglobin.total |
MFr |
Bld |
Pt |
Qn |
|
|
ACTIVE |
Carboxyhemoglobin/Hemoglobin.total in Blood |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CHEM |
|
20563-3 |
|
|
|
|
Both |
|
|
|
0 |
COHgb MFr Bld |
|
|
|
Y |
|
Blood; Carbon monoxide.hemoglobin; Carbonmonoxyhemoglobin; Carbonyl haemoglobin; Carbonyl hemoglobin; Carbonyl Hgb; Carboxyhaemoglobin; Carboxyhemoglob; Chemistry; CO haemoglobin; CO hemoglobin; COHb; COHgb; Haemoglobin; Hb; HbCO; Hemoglobin bound with carbon dioxide; Hgb; Lung; Mass Fraction; Percent; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Tot; Totl; UniversalLabOrders; WB; Whole blood |
2.73 |
1.0m |
|
|
|
|
|
|
|
% |
|
|
|
0 |
| 20564-1 |
Oxygen saturation |
MFr |
Bld |
Pt |
Qn |
|
|
ACTIVE |
Oxygen saturation in Blood |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
HEMODYN.MOLEC |
|
20564-1 |
|
|
|
|
Both |
|
|
|
0 |
SaO2 % Bld |
|
|
|
Y |
|
Blood; Hemodynamics; HEMODYNAMICS.MOLEC; Lung; Mass fraction; O2; Percent; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; SaO2; SAT; Satn; SO2; tO2; WB; Whole blood |
2.73 |
1.0m |
|
|
|
|
|
|
|
% |
|
|
|
0 |
| 20565-8 |
Carbon dioxide |
SCnc |
Bld |
Pt |
Qn |
|
|
ACTIVE |
Carbon dioxide, total [Moles/volume] in Blood |
|
MIN |
DefinitionDescription |
|
|
mmol/L |
|
|
|
|
|
|
CHEM |
|
20565-8 |
|
|
|
|
Both |
|
|
|
0 |
CO2 Bld-sCnc |
|
|
|
Y |
|
Blood; Carbonic anhydride; cCO2; Chemistry; CO2; CO2 TOTAL; CO2CT; ctCO2; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; tCO2; WB; Whole blood |
2.73 |
1.0m |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |
| 20566-6 |
Colony count |
NCnc |
Ctp |
Pt |
Qn |
Culture |
|
ACTIVE |
Colony count [#/volume] in Catheter tip by Culture |
|
MIN |
DefinitionDescription |
|
|
/mL |
|
|
|
|
|
|
MICRO |
|
20566-6 |
|
Culture |
|
|
Both |
|
|
|
0 |
CC # Cath Tip Cult |
|
|
|
Y |
|
#; ABS; absolute; absolutes; C&S; Cath Tip; Catheter tip; CC; Cnt; Colonies; Count; Count/volume; CT; Cult; Cultures; ID; Infectious Disease; InfectiousDisease; Microbiology; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random |
2.42 |
1.0m |
|
|
|
|
|
|
|
/mL |
|
|
|
0 |
| 20567-4 |
Ferritin |
MCnc |
Ser/Plas |
Pt |
Qn |
IA |
|
ACTIVE |
Ferritin [Mass/volume] in Serum or Plasma by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
CHEM |
|
20567-4 |
|
IA |
|
|
Both |
|
|
|
0 |
Ferritin SerPl IA-mCnc |
|
|
|
Y |
|
Chemistry; EIA; ELFA; ELISA; Enzyme immunoassay; Ferr; IAA; Level; Mass concentration; MEIA; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS |
2.73 |
1.0m |
|
|
|
|
|
|
|
ng/mL |
|
|
The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 20568-2 |
Prolactin |
MCnc |
Ser/Plas |
Pt |
Qn |
IA |
|
ACTIVE |
Prolactin [Mass/volume] in Serum or Plasma by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
CHEM |
|
20568-2 |
|
IA |
|
|
Both |
|
|
|
0 |
Prolactin SerPl IA-mCnc |
|
|
|
Y |
|
Chemistry; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Lactotropic hormone; Lactotropin; Level; Mammatropic hormone; Mammotropin; Mass concentration; MEIA; Pl; Plasma; Plsm; Point in time; PRL; Prol; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS; UniversalLabOrders |
2.73 |
1.0m |
|
|
|
|
|
|
|
ng/mL |
|
|
The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 20569-0 |
Creatine kinase.MB/Creatine kinase.total |
CFr |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Creatine kinase.MB/Creatine kinase.total in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CHEM |
|
20569-0 |
|
|
|
|
Observation |
|
|
|
0 |
CK MB CFr SerPl |
|
|
|
Y |
|
Cardio; Cardiology; Catalytic Fraction; Chemistry; CK; CK 2; CK MB; CK-2; CKMB; CK-MB; CPK; Creatine phosphokinase; Heart Disease; Percent; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tot; Totl |
2.73 |
1.0m |
|
|
|
|
|
|
|
% |
|
|
|
0 |
| 2057-8 |
Catecholamines |
MCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Catecholamines [Mass/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
ug/L |
|
|
|
|
|
|
CHEM |
|
2057-8 |
|
|
|
|
Both |
|
|
|
0 |
Catechols Ur-mCnc |
|
|
|
Y |
|
Cate; Catec; Catech; Catechol; Catecholamine; Catecholamines.total; Catechols; Chemistry; Endocrine; Endocrinology; Epinephrine+norepinephrine+dopamine; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.73 |
1 |
|
|
|
|
|
|
|
ug/L |
|
|
|
0 |
| 20570-8 |
Erythrocyte/Blood |
VFr |
Bld |
Pt |
Qn |
Calculated |
|
ACTIVE |
Hematocrit [Volume Fraction] of Blood by calculation |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
HEM/BC |
|
20570-8 |
|
Calculated |
|
|
Both |
|
|
|
0 |
Hct VFr Bld Calc |
|
|
|
Y |
|
Blood; Calc; Calculation; Discocyte; Erc; Erythrocytes; HEMATOLOGY/CELL COUNTS; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; RBC; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; UniversalLabOrders; Volfr; Volume fraction; WB; Whole blood |
2.79 |
1.0m |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT:Hematocrit as a component is not an adequate description for a ratio, therefore Hematocrit is kept as a synonym, and the actual component is expressed as it should be:Erythrocyte/blood; |
0 |
| 20571-6 |
Hepatitis C virus RNA |
NCnc |
Ser/Plas |
Pt |
Qn |
Probe.amp.sig |
|
ACTIVE |
Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by Probe with signal amplification |
|
MIN |
DefinitionDescription |
|
|
10*6 eq/mL |
|
|
|
|
|
|
MICRO |
|
20571-6 |
|
Probe.amp.sig |
|
|
Both |
|
|
|
0 |
HCV RNA # SerPl Probe+sig amp |
|
|
|
Y |
|
#; ABS; absolute; absolutes; Amplif; Amplification; Amplified; bDNA; Bdn-A; Branched Chain DNA; Cnt; Count; Count/volume; CT; DNA NUCLEIC ACID PROBE; DNA probe; HC; HCV; Hep; Hep C; Hepatis; Hepatit; Hepatology; HPA; Hybidization Protection Assay; Hybrid Capture; Hybrid Capture nucleic acid hybridization; ID; Infectious Disease; InfectiousDisease; Liver; Microbiology; Number concentration; Number Concentration (count/vol); Pl; Plasma; Plsm; Point in time; Probe amp; Probe with ampification; Probe with signal amplification; Probe+sig amp; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Viral load |
2.73 |
1.0m |
|
|
|
|
|
|
|
10*6{viral equivalents}/mL |
|
|
|
0 |
| 20572-4 |
Hemoglobin A/Hemoglobin.total |
MFr |
Bld |
Pt |
Qn |
Electrophoresis |
|
ACTIVE |
Hemoglobin A/Hemoglobin.total in Blood by Electrophoresis |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
HEM/BC |
|
20572-4 |
|
Electrophoresis |
|
|
Observation |
|
|
|
0 |
Hgb A MFr Bld Elph |
|
|
|
Y |
|
Blood; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; Haemoglobin; Hb; HbA; HEMATOLOGY/CELL COUNTS; Hgb; Hgb A; Mass Fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; WB; Whole blood |
2.73 |
1.0m |
|
|
|
|
|
|
|
% |
|
|
|
0 |
| 20573-2 |
Histoplasma capsulatum mycelial phase Ab |
Titr |
Ser |
Pt |
SemiQn |
Comp fix |
|
ACTIVE |
Histoplasma capsulatum mycelial phase Ab [Titer] in Serum by Complement fixation |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
20573-2 |
|
Comp fix |
|
|
Both |
|
|
|
0 |
H capsul Myc Ab Titr Ser CF |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CF; Comp fixation; Compfix; Complement fixation; Dilution factor; Dilution Factor (Titer); H capsul; H capsul Myc; H capsulatum; H farciminosum; Histo; Histopl; Histoplasma farciminosum; Histoplasmin; Histoplasmos; Histoplasmosis; ID; Infectious Disease; InfectiousDisease; Microbiology; Mycel; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr |
2.75 |
1.0m |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
